-transparent.png){kind=logo}
Two cell lines of human hybridomas were fused to generate hybrid antibodies. One human hybridoma cell line was HT2 producing IgM monoclonal antibody (MAb) reactive to carboxy peptidase A (Cpase) and double stranded DNA (ds DNA) and another was SU-1-D2 secreting IgM MAb reactive to ds DNA but not to Cpase. Most hybrid hybridomas obtained by fusion of the two hybridomas secreted hybrid antibodies exhibiting increased antigen binding strengths. All of the hybrid antibodies with increased binding strengths against Cpase and ds DNA contained only the light chains derived from SU-1-D2. These results suggested that increase in the binding strength of the hybrid antibodies resulted from heterogeneous association of H and L chains derived from HT2 and SU-1-D2 cells.
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
January 1984,
Gan to kagaku ryoho. Cancer & chemotherapy,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
May 1987,
Parasite immunology,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
December 1985,
Blood,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
October 1985,
Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
February 2020,
Antibodies (Basel, Switzerland),
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
January 1986,
Methods in enzymology,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
January 1988,
International journal of cancer. Supplement = Journal international du cancer. Supplement,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
June 2013,
Nature protocols,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
April 1983,
Revue francaise de transfusion et immuno-hematologie,
H Tachibana, and
S Shirahata, and
H Kawahara, and
H Murakami
June 1987,
Veterinary immunology and immunopathology,
